Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Baxter
Healthtrust
Covington
Cantor Fitzgerald
Colorcon
AstraZeneca
US Department of Justice
Johnson and Johnson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,785,420

« Back to Dashboard

Which drugs does patent 8,785,420 protect, and when does it expire?


Patent 8,785,420 protects EPIDUO FORTE and is included in one NDA. There has been one Paragraph IV challenge on Epiduo Forte.

This patent has twenty-two patent family members in eighteen countries.

Summary for Patent: 8,785,420

Title:Combination/association of adapalene and benzoyl peroxide for treating acne lesions
Abstract: Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).
Inventor(s): Abou Chacra Vernet; Marie-Line (Nice, FR), Gross; Denis (Callian, FR), Loesche; Christian (Valbonne, FR), Poncet; Michel (Mougins, FR)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:13/351,986
Patent Claim Types:
see list of patent claims
Use; Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Galderma Labs
EPIDUO FORTE
adapalene; benzoyl peroxide
GEL;TOPICAL207917-001Jul 15, 2015RXYesYes► Subscribe► Subscribe TREATMENT OF ACNE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,785,420

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France06 52968Jul 13, 2006

Non-Orange Book Patents for Patent: 8,785,420

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,071,644Combinations of adapalene and benzoyl peroxide for treating acne lesions► Subscribe
8,129,362Combination/association of adapalene and benzoyl peroxide for treating acne lesions► Subscribe
8,080,537Combinations of adapalene and benzoyl peroxide for treating acne lesions► Subscribe
8,445,543Combinations of adapalene and benzoyl peroxide for treating acne lesions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,785,420

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina061989► Subscribe
Australia2007274288► Subscribe
BrazilPI0713182► Subscribe
Canada2656456► Subscribe
China101541320► Subscribe
Colombia6150136► Subscribe
Cyprus1114473► Subscribe
Denmark2046318► Subscribe
European Patent Office2046318► Subscribe
European Patent Office2450035► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKesson
Express Scripts
Deloitte
Boehringer Ingelheim
Chubb
US Department of Justice
Farmers Insurance
Julphar
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot